Unknown

Dataset Information

0

Evaluation of SARS-CoV-2 main protease and inhibitor interactions using dihedral angle distributions and radial distribution function

ABSTRACT: In order to evaluate the interactions between a potential drug candidate like inhibitor N3 and the residues in substrate binding site of SARS-CoV-2 main protease ( Coronavirus main protease; Inhibitor interactions; Radial distribution function; Dihedral angle distributions; Binding energy

SUBMITTER: Lamichhane T 

PROVIDER: S-EPMC8525048 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown A cyclic peptide inhibitor of the SARS-CoV-2 main protease.
| S-EPMC8096527 | biostudies-literature
Unknown Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332.
| S-EPMC8533666 | biostudies-literature
Unknown SARS-CoV and SARS-CoV-2 main protease residue interaction networks change when bound to inhibitor N3.
| S-EPMC7347504 | biostudies-literature
Unknown Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2.
| S-EPMC8357482 | biostudies-literature
Unknown Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening
| S-EPMC8612299 | biostudies-literature
Unknown 2-Phenoxyacetamide derivatives as SARS-CoV-2 main protease inhibitor: In silico studies.
| S-EPMC8666106 | biostudies-literature
Unknown Pan-3C Protease Inhibitor Rupintrivir Binds SARS-CoV-2 Main Protease in a Unique Binding Mode.
| S-EPMC8457326 | biostudies-literature
Unknown Potential SARS-CoV-2 main protease inhibitors.
| S-EPMC7724992 | biostudies-literature
Unknown Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates.
| S-EPMC7385649 | biostudies-literature
Unknown Topological analysis of SARS CoV-2 main protease.
| S-EPMC7286701 | biostudies-literature